chr3-50300514-G-C
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_033159.4(HYAL1):āc.1277C>Gā(p.Ala426Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00104 in 1,614,210 control chromosomes in the GnomAD database, including 14 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Consequence
NM_033159.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
HYAL1 | NM_033159.4 | c.1277C>G | p.Ala426Gly | missense_variant | 4/4 | ENST00000395144.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
HYAL1 | ENST00000395144.7 | c.1277C>G | p.Ala426Gly | missense_variant | 4/4 | 1 | NM_033159.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00569 AC: 866AN: 152214Hom.: 8 Cov.: 33
GnomAD3 exomes AF: 0.00149 AC: 374AN: 251432Hom.: 3 AF XY: 0.00110 AC XY: 149AN XY: 135902
GnomAD4 exome AF: 0.000560 AC: 818AN: 1461878Hom.: 6 Cov.: 31 AF XY: 0.000477 AC XY: 347AN XY: 727240
GnomAD4 genome AF: 0.00570 AC: 868AN: 152332Hom.: 8 Cov.: 33 AF XY: 0.00560 AC XY: 417AN XY: 74474
ClinVar
Submissions by phenotype
Deficiency of hyaluronoglucosaminidase Benign:3
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 13, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
Benign, no assertion criteria provided | clinical testing | Natera, Inc. | Nov 11, 2019 | - - |
not provided Benign:1
Benign, no assertion criteria provided | clinical testing | Mayo Clinic Laboratories, Mayo Clinic | May 17, 2017 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at